Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people.
作者信息
Juliusson Gunnar, Höglund Martin, Lehmann Sören
机构信息
Department of Hematology, Skåne University Hospital, Lund, and Department of Hematology, Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund.
Department of Medical Sciences, Uppsala University, Uppsala.
出版信息
Haematologica. 2020 Jan 31;105(2):249-251. doi: 10.3324/haematol.2019.238857. Print 2020.
Abstract
摘要
相似文献
1
Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people.低强度、高强度还是联合治疗：老年急性髓系白血病治疗的新范式
Haematologica. 2020 Jan 31;105(2):249-251. doi: 10.3324/haematol.2019.238857. Print 2020.
2
HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia.HAG方案可提高低细胞性急性髓系白血病成年患者的生存率。
Oncotarget. 2016 Jan 19;7(3):3623-34. doi: 10.18632/oncotarget.6211.
3
Combinational treatment of TPEN and TPGS induces apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo.TPEN 和 TPGS 的联合治疗在体外和体内诱导急性淋巴细胞白血病和慢性髓性白血病细胞凋亡。
Med Oncol. 2022 May 17;39(7):109. doi: 10.1007/s12032-022-01697-w.
4
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.195 例老年骨髓增生异常综合征和急性髓系白血病患者的老年病学和生活质量评估检测参数对预后有高度预测性。
Haematologica. 2013 Feb;98(2):208-16. doi: 10.3324/haematol.2012.067892. Epub 2012 Aug 8.
5
Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients.成人低细胞性急性髓细胞白血病：123 例患者的临床结局分析。
Haematologica. 2012 Feb;97(2):235-40. doi: 10.3324/haematol.2011.046672. Epub 2011 Nov 4.
6
Treatment of Elderly Patients With Acute Myeloid Leukemia.老年急性髓系白血病患者的治疗
Curr Treat Options Oncol. 2017 Jan;18(1):2. doi: 10.1007/s11864-017-0445-5.
7
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.一项多中心二期临床试验，评估地西他滨作为不适合诱导化疗的老年急性髓系白血病患者的一线治疗药物。
Haematologica. 2012 Mar;97(3):393-401. doi: 10.3324/haematol.2011.048231. Epub 2011 Nov 4.
8
Toward a better management of older patients with acute myeloid leukemia.迈向对老年急性髓系白血病患者的更好管理。
Future Oncol. 2015;11(5):715-8. doi: 10.2217/fon.15.8.
9
Hypo-triploid acute myeloid leukemia with isochromosome 11q.伴有11号染色体长臂等臂染色体的亚三倍体急性髓系白血病
Int J Hematol. 1992 Dec;56(3):191-5.
10
Impact of allogeneic hematopoietic cell transplantation on the outcome of older patients with acute myeloid leukemia.异基因造血细胞移植对老年急性髓系白血病患者预后的影响。
Best Pract Res Clin Haematol. 2017 Dec;30(4):320-326. doi: 10.1016/j.beha.2017.09.004. Epub 2017 Sep 22.
引用本文的文献
1
Acquired Resistance to Decitabine Associated with the Deoxycytidine Kinase A180P Mutation: Implications for the Order of Hypomethylating Agents in Myeloid Malignancies Treatment.与脱氧胞苷激酶A180P突变相关的地西他滨获得性耐药：对髓系恶性肿瘤治疗中去甲基化药物用药顺序的影响
Int J Mol Sci. 2025 May 25;26(11):5083. doi: 10.3390/ijms26115083.
2
Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations.诱导急性髓系白血病细胞凋亡：机制与局限性
Heliyon. 2024 Dec 19;11(1):e41355. doi: 10.1016/j.heliyon.2024.e41355. eCollection 2025 Jan 15.
3
Evaluating Fitness in Older Acute Myeloid Leukemia Patients: Balancing Therapy and Treatment Risks.评估老年急性髓系白血病患者的身体状况：平衡治疗与治疗风险
J Clin Med. 2024 Oct 25;13(21):6399. doi: 10.3390/jcm13216399.
4
Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol.白血病细胞对5-氮杂胞苷的耐药性：对相同诱导方案的不同反应。
Cancers (Basel). 2023 Jun 5;15(11):3063. doi: 10.3390/cancers15113063.
5
Determination of fitness and therapeutic options in older patients with acute myeloid leukemia.老年急性髓系白血病患者的体能状况评估和治疗选择。
Am J Hematol. 2021 Apr 1;96(4):493-507. doi: 10.1002/ajh.26079. Epub 2021 Jan 12.
本文引用的文献
1
Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years.≥60岁新诊断急性髓系白血病患者甲基化治疗模式及疗效的真实世界数据。
Br J Haematol. 2020 Apr;189(1):e13-e16. doi: 10.1111/bjh.16410. Epub 2020 Feb 26.
2
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia.伴有阿扎胞苷的维奈托克治疗未经治疗的急性髓系白血病患者的真实世界经验。
Blood Adv. 2019 Oct 22;3(20):2911-2919. doi: 10.1182/bloodadvances.2019000243.
3
Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period.50至75岁急性髓系白血病男性患者在20年期间生存率提高。
Blood. 2019 Oct 31;134(18):1558-1561. doi: 10.1182/blood.2019001728.
4
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia.比较 70 岁及以上急性髓系白血病患者常用一线方案的生存结局。
Haematologica. 2020 Jan 31;105(2):398-406. doi: 10.3324/haematol.2018.208637. Print 2020.
5
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients.强化化疗后阿扎胞苷维持治疗可改善老年 AML 患者的DFS。
Blood. 2019 Mar 28;133(13):1457-1464. doi: 10.1182/blood-2018-10-879866. Epub 2019 Jan 10.
6
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.维奈托克联合地西他滨或阿扎胞苷治疗初治老年急性髓系白血病患者。
Blood. 2019 Jan 3;133(1):7-17. doi: 10.1182/blood-2018-08-868752. Epub 2018 Oct 25.
7
Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia.表观遗传疗法：急性髓系白血病中的阿扎胞苷和地西他滨
Expert Rev Hematol. 2018 May;11(5):361-371. doi: 10.1080/17474086.2018.1453802. Epub 2018 Mar 27.
8
Azacitidine in adult patients with acute myeloid leukemia.阿扎胞苷用于成年急性髓系白血病患者。
Crit Rev Oncol Hematol. 2017 Aug;116:159-177. doi: 10.1016/j.critrevonc.2017.05.010. Epub 2017 Jun 3.
9
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.阿扎胞苷用于急性髓系白血病患者的一线治疗：通过国际3期试验数据与AGMT研究组奥地利阿扎胞苷登记处登记数据的直接比较确立的可重复性疗效
Int J Mol Sci. 2017 Feb 15;18(2):415. doi: 10.3390/ijms18020415.
10
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理：2017年国际专家小组的欧洲白血病网络（ELN）建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
Zotero 插件